Skip to content
Clinical Trials – home

Kiepury Clinic Malgorzata Jarnot Specjalistyczna Praktyka Ginekologiczno-Położnicza

Verified siteinfo

Poland Kiepury 47, 41-209 Sosnowiec, Poland

  • 2 trials recruiting
  • Asthma · Colitis ulcerative · Crohn's disease
  • Adult patients

About Specializations

Kiepury Clinic Malgorzata Jarnot Specjalistyczna Praktyka Ginekologiczno-Położnicza in Sosnowiec, Poland specialises in clinical trials of conditions such as Asthma, Colitis ulcerative, Crohn's disease, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases

The Kiepury Clinic Malgorzata Jarnot Specjalistyczna Praktyka Ginekologiczno-Położnicza concentrates on immune system diseases, with a primary focus on uncontrolled moderate to severe eosinophilic asthma.

  • Testing the novel oral agent KT-621 for efficacy
  • Comparing multiple dosing regimens against placebo
  • Exploring eosinophil-driven mechanisms in severe asthma

A dedicated team of five investigators in Sosnowiec conducts these studies to improve treatment options and quality of life for patients struggling with severe asthma.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Kiepury 4741-209 SosnowiecPoland
Recruiting now
2 trials
Conditions studied
3
Partner status
Verified site

More sites in SosnowiecPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Crohn's disease

Recruiting

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Asthma

Recruiting

A study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Kymera Therapeutics Inc.

Asthma

Not yet recruiting

Long‑Term Safety and Tolerability Study of Oral KT‑621 in Adults with Uncontrolled Moderate‑to‑Severe Eosinophilic Asthma

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Kymera Therapeutics Inc.

Colitis ulcerative

Not recruiting

Study of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.